The background and philosophy behind daylight photodynamic therapy

Area of Science:

• Biomedical Engineering
• Photomedicine
• Dermatology

Background:

• Conventional photodynamic therapy (PDT) involves photosensitizer application followed by a waiting period before illumination.
• This delay can lead to significant pain and inflammation during treatment, limiting patient tolerance and clinic capacity.
• Current pain management options for PDT are often insufficient, and post-treatment inflammation causes considerable downtime.

Purpose of the Study:

• To investigate a modified PDT approach using daylight for illumination to reduce pain and inflammation.
• To explore the potential of continuous activation of protoporphyrin IX (PpIX) during its formation to mitigate side effects.
• To assess the feasibility of at-home PDT treatment using natural daylight.

Main Methods:

• Modified PDT protocol eliminating the waiting period between photosensitizer application and illumination.
• Utilizing natural daylight or daylight-emitting light sources for continuous activation of PpIX.
• Investigating the mechanism of continuous PpIX activation on cellular processes, focusing on mitochondrial effects.

Main Results:

• Continuous activation of PpIX during its formation significantly minimized pain and inflammation compared to conventional PDT.
• The photodynamic effect was localized to mitochondria, primarily inducing apoptosis with reduced inflammatory response.
• Daylight-PDT enabled treatment outside the clinic, potentially at home, reducing patient crowding and strain on healthcare facilities.

Conclusions:

• Daylight-PDT offers a promising alternative to conventional PDT by effectively reducing pain and inflammation.
• Continuous activation of PpIX during its formation is key to minimizing side effects and improving patient experience.
• This approach enhances treatment accessibility and convenience, allowing for at-home application and reducing healthcare system burden.